107 related articles for article (PubMed ID: 21697762)
1. Transforming growth factor β1 contributes to the invasiveness of pancreatic ductal adenocarcinoma cells through the regulation of CD24 expression.
Kitaura Y; Chikazawa N; Tasaka T; Nakano K; Tanaka M; Onishi H; Katano M
Pancreas; 2011 Oct; 40(7):1034-42. PubMed ID: 21697762
[TBL] [Abstract][Full Text] [Related]
2. The effect of aberrant maspin expression on the invasive ability of pancreatic ductal adenocarcinoma cells.
Hong SN; Lee JK; Choe WH; Ha HY; Park K; Sung IK; Lee KT; Kim JJ; Rhee JC
Oncol Rep; 2009 Feb; 21(2):425-30. PubMed ID: 19148518
[TBL] [Abstract][Full Text] [Related]
3. Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas.
Ikenaga N; Ohuchida K; Mizumoto K; Yu J; Kayashima T; Hayashi A; Nakata K; Tanaka M
Hum Pathol; 2010 Oct; 41(10):1466-74. PubMed ID: 20619441
[TBL] [Abstract][Full Text] [Related]
4. Effects of bone sialoprotein on pancreatic cancer cell growth, invasion and metastasis.
Kayed H; Kleeff J; Keleg S; Felix K; Giese T; Berger MR; Büchler MW; Friess H
Cancer Lett; 2007 Jan; 245(1-2):171-83. PubMed ID: 16488077
[TBL] [Abstract][Full Text] [Related]
5. Extracellular matrix-mediated membrane-type 1 matrix metalloproteinase expression in pancreatic ductal cells is regulated by transforming growth factor-beta1.
Ottaviano AJ; Sun L; Ananthanarayanan V; Munshi HG
Cancer Res; 2006 Jul; 66(14):7032-40. PubMed ID: 16849548
[TBL] [Abstract][Full Text] [Related]
6. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
[TBL] [Abstract][Full Text] [Related]
7. Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer.
Zhang Y; Wei J; Wang H; Xue X; An Y; Tang D; Yuan Z; Wang F; Wu J; Zhang J; Miao Y
Oncol Rep; 2012 May; 27(5):1599-605. PubMed ID: 22322379
[TBL] [Abstract][Full Text] [Related]
8. Galectin-1 secreted by activated stellate cells in pancreatic ductal adenocarcinoma stroma promotes proliferation and invasion of pancreatic cancer cells: an in vitro study on the microenvironment of pancreatic ductal adenocarcinoma.
Xue X; Lu Z; Tang D; Yao J; An Y; Wu J; Li Q; Gao W; Xu Z; Qian Z; Dai C; Wei J; Miao Y; Jiang K
Pancreas; 2011 Aug; 40(6):832-9. PubMed ID: 21747316
[TBL] [Abstract][Full Text] [Related]
9. Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma.
Wente MN; Gaida MM; Mayer C; Michalski CW; Haag N; Giese T; Felix K; Bergmann F; Giese NA; Friess H
Int J Oncol; 2008 Aug; 33(2):297-308. PubMed ID: 18636150
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of ankyrin-B expression reduces growth and invasion of human pancreatic ductal adenocarcinoma.
Chen Y; Löhr M; Jesnowski R
Pancreatology; 2010; 10(5):586-96. PubMed ID: 21042036
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: role in malignant transformation of pancreatic cancer.
Geismann C; Morscheck M; Koch D; Bergmann F; Ungefroren H; Arlt A; Tsao MS; Bachem MG; Altevogt P; Sipos B; Fölsch UR; Schäfer H; Müerköster SS
Cancer Res; 2009 May; 69(10):4517-26. PubMed ID: 19435915
[TBL] [Abstract][Full Text] [Related]
12. Insig2 is overexpressed in pancreatic cancer and its expression is induced by hypoxia.
Kayashima T; Nakata K; Ohuchida K; Ueda J; Shirahane K; Fujita H; Cui L; Mizumoto K; Tanaka M
Cancer Sci; 2011 Jun; 102(6):1137-43. PubMed ID: 21443541
[TBL] [Abstract][Full Text] [Related]
13. Gamma-aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor pi subunit.
Takehara A; Hosokawa M; Eguchi H; Ohigashi H; Ishikawa O; Nakamura Y; Nakagawa H
Cancer Res; 2007 Oct; 67(20):9704-12. PubMed ID: 17942900
[TBL] [Abstract][Full Text] [Related]
14. Differential roles of Src in transforming growth factor-ß regulation of growth arrest, epithelial-to-mesenchymal transition and cell migration in pancreatic ductal adenocarcinoma cells.
Ungefroren H; Sebens S; Groth S; Gieseler F; Fändrich F
Int J Oncol; 2011 Mar; 38(3):797-805. PubMed ID: 21225226
[TBL] [Abstract][Full Text] [Related]
15. Semaphorin 4D, a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexinB1, in pancreatic cancer.
Kato S; Kubota K; Shimamura T; Shinohara Y; Kobayashi N; Watanabe S; Yoneda M; Inamori M; Nakamura F; Ishiguro H; Nakaigawa N; Nagashima Y; Taguri M; Kubota Y; Goshima Y; Morita S; Endo I; Maeda S; Nakajima A; Nakagama H
Cancer Sci; 2011 Nov; 102(11):2029-37. PubMed ID: 21812859
[TBL] [Abstract][Full Text] [Related]
16. Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis.
Maruyama Y; Ono M; Kawahara A; Yokoyama T; Basaki Y; Kage M; Aoyagi S; Kinoshita H; Kuwano M
Cancer Res; 2006 Jun; 66(12):6233-42. PubMed ID: 16778198
[TBL] [Abstract][Full Text] [Related]
17. CD10+ pancreatic stellate cells enhance the progression of pancreatic cancer.
Ikenaga N; Ohuchida K; Mizumoto K; Cui L; Kayashima T; Morimatsu K; Moriyama T; Nakata K; Fujita H; Tanaka M
Gastroenterology; 2010 Sep; 139(3):1041-51, 1051.e1-8. PubMed ID: 20685603
[TBL] [Abstract][Full Text] [Related]
18. BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion.
Kayed H; Bekasi S; Keleg S; Michalski CW; Giese T; Friess H; Kleeff J
Mol Cancer; 2007 Dec; 6():83. PubMed ID: 18163903
[TBL] [Abstract][Full Text] [Related]
19. Netrin-1 mediates early events in pancreatic adenocarcinoma progression, acting on tumor and endothelial cells.
Dumartin L; Quemener C; Laklai H; Herbert J; Bicknell R; Bousquet C; Pyronnet S; Castronovo V; Schilling MK; Bikfalvi A; Hagedorn M
Gastroenterology; 2010 Apr; 138(4):1595-606, 1606.e1-8. PubMed ID: 20080097
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of LINC01638 lncRNA inhibits migration and invasion of pancreatic ductal adenocarcinoma cells by reducing TGF‑β signaling.
Lu H; Ye J; Zhang L; Li M; Lu S; Yang D; Hu W
Mol Med Rep; 2019 Nov; 20(5):4533-4539. PubMed ID: 31702018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]